Roth Yiftach 4

What Happened

• Yiftach Roth, Chief Scientist of Brainsway Ltd. (BWAY), reported open-market sales totaling 7,000 ordinary shares (may be represented by ADSs — see footnote). The sales occurred on June 1–2, 2026 and generated gross proceeds of approximately NIS 301,187.
• Reported sale details by lot: 2,000 shares at NIS 43.64 (≈ NIS 87,280), 2,000 shares at NIS 43.45 (≈ NIS 86,900), 1,000 shares at NIS 43.00 (≈ NIS 43,000), and 2,000 shares at NIS 42.0035 (≈ NIS 84,007). Each line was coded as a sale (S), via open market or private sale.

Key Details

• Transaction dates and prices: June 1, 2026 (two 2,000-share lots at NIS 43.64 and NIS 43.45); June 2, 2026 (1,000 shares at NIS 43.00; 2,000 shares at NIS 42.0035).
• Total sold: 7,000 shares; approximate gross proceeds: NIS 301,187.
• Holdings after the transactions: reported holdings include 15,000 ordinary shares plus unvested RSUs to receive 5,000 ordinary shares (1,250 vest on March 10, 2027; remainder vests quarterly through March 10, 2030). Some shares are held jointly with spouse (per filing footnote).
• Footnotes: F1 notes ordinary shares may be represented by ADSs (1 ADS = 1 ordinary share). F2–F6 provide the per-share sale prices used above. F3 explains the composition of reported holdings and vesting schedule for RSUs.
• Filing timeliness: Form 4 was filed June 3, 2026 for transactions on June 1–2, 2026 — within the standard 2-business-day window (timely).

Context

• These were outright sales (disposals) in the open market. Sales by executives can reflect many reasons (diversification, taxes, personal liquidity) and do not by themselves indicate company prospects.
• No 10b5-1 trading plan, option exercises, gifts, or tax-withholding transactions are disclosed in this Form 4.